Showing results (31-40 of 861) with videos related to

Sort By:
Pageof 87
Neurology|September 19, 2007
A composite score to predict short-term disease activity in patients with relapsing-remitting MSMaria Pia Sormani, Marco Rovaris, Giancarlo Comi, et al.
International Immunopharmacology|August 12, 2008
Carry-over effect on IFN-gamma production induced by allergen-specific immunotherapyGiorgio Ciprandi, Maria Pia Sormani, Gilberto Filaci, et al.
Multiple Sclerosis and Related Disorders|December 10, 2020
Effect size - one size doesn't fit allGary Cutter
Multiple Sclerosis and Related Disorders|November 13, 2019
EFFECT size or statistical significance, where to put your moneyGary Cutter
Neurology(R) Neuroimmunology & Neuroinflammation|May 16, 2019
Different MRI patterns in MS worsening after stopping fingolimodCaterina Lapucci, Damiano Baroncini, Maria Cellerino, et al.
European Journal of Neurology|December 4, 2020
Rapid eye movement sleep behavior disorder: A proof-of-concept neuroprotection study for prodromal synucleinopathiesDario Arnaldi, Francesco Famà, Nicola Girtler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2016
NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugsMaria Pia Sormani, Paolo A Muraro, Riccardo Saccardi, et al.
Immunology Letters|February 22, 2008
Body mass index in Th1 and Th2 diseasesBarbara Maria Colombo, Giuseppe Murdaca, Giorgio Ciprandi, et al.
Plos One|March 17, 2016
The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-AnalysisPierre Branger, Jean-Jacques Parienti, Maria Pia Sormani, et al.
European Journal of Neurology|March 8, 2022
Prevalence of disability improvement in relapsing-remitting multiple sclerosis patients treated with cladribine tabletsAlessio Signori, Marta Ponzano, Nektaria Alexandri, et al.
Pageof 87